EMEA-003081-PIP01-21-M02 - paediatric investigation plan
(1R,2S,5S)-N-((1S)-1-Cyano-2-((3S)-2-oxopyrrolidin-3-yl)ethyl)-3-((2S)-3,3-dimethyl-2-(2,2,2- trifluoroacetamido)butanoyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide
PIPHuman
Pfizer Europe MA EEIG
Tel. +44 (0)1304 646 607
E-mail: pip_enquiries@pfizer.com